Asia Pacific Exosome Diagnostic and Therapeutic Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Exosome Diagnostic and Therapeutic Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Exosome Diagnostic and Therapeutic Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Exosome Diagnostic and Therapeutic Market Regional Analysis

6.2 Asia Pacific Exosome Diagnostic and Therapeutic Market Revenue 2017-2027 (US$ Thousand)

6.3 Asia Pacific Exosome Diagnostic and Therapeutic Market Forecast Analysis

7. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis – by Application

7.1 Diagnostic

7.1.1 Overview
7.1.2 Diagnostic: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

7.2 Therapeutic

7.2.1 Overview
7.2.2 Therapeutic: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

8. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis – by Product

8.1 Instruments

8.1.1 Overview
8.1.2 Instruments: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

8.2 Reagents

8.2.1 Overview
8.2.2 Reagents: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

8.3 Software

8.3.1 Overview
8.3.2 Software: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

9. Asia Pacific Exosome Diagnostic and Therapeutic Market Analysis – by End User

9.1 Cancer Institute

9.1.1 Overview
9.1.2 Cancer Institute: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

9.2 Hospitals

9.2.1 Overview
9.2.2 Hospitals: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

9.3 Diagnostic Centers

9.3.1 Overview
9.3.2 Diagnostic Centers: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

9.4 Other End Users

9.4.1 Overview
9.4.2 Other End Users: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast, 2017-2027 (US$ Thousand)

10. Asia Pacific Exosome Diagnostic and Therapeutic Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

10.2.1.1.1 China: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Application
10.2.1.1.2 China: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Product
10.2.1.1.3 China: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

10.2.1.2.1 India: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Application
10.2.1.2.2 India: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Product
10.2.1.2.3 India: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

10.2.1.3.1 Japan: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Application
10.2.1.3.2 Japan: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Product
10.2.1.3.3 Japan: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

10.2.1.4.1 Australia: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Application
10.2.1.4.2 Australia: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Product
10.2.1.4.3 Australia: Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Application
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by Product
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Exosome Diagnostic and Therapeutic Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Cell Guidance Systems

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Evomic Science LLC

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Exosome Diagnostics

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 ITH, Immune Therapy Holdings AB

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Miltenyi Biotec

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Norgen Biotek Corp

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Reneuron Group Plc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Exosome Diagnostic and Therapeutic Market

Analysis By Application (Diagnostic and Therapeutic); Product (Instruments, Reagents, and Software); End User (Cancer Institute, Hospitals, Diagnostic Centers, and Other End Users), and Country